Detalhe da pesquisa
1.
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
Blood
; 139(11): 1694-1706, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995355
2.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Blood
; 136(13): 1499-1506, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603426
3.
Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.
Blood
; 133(26): 2790-2799, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992266
4.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
5.
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.
Ann Intern Med
; 172(4): 229-239, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31958813
6.
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies.
Biol Blood Marrow Transplant
; 26(10): 1811-1818, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693210
7.
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(7): 1332-1341, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234377
8.
History of hematopoietic cell transplantation: challenges and progress.
Haematologica
; 105(12): 2716-2729, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054108
9.
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia.
Haematologica
; 105(6): 1731-1737, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582553
10.
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
Am J Hematol
; 95(1): 48-56, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637757
11.
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Biol Blood Marrow Transplant
; 25(7): 1331-1339, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711779
12.
Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting.
Biol Blood Marrow Transplant
; 25(11): 2152-2159, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31255743
13.
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
Biol Blood Marrow Transplant
; 25(5): 1045-1052, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30500442
14.
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.
Haematologica
; 104(6): 1221-1229, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630975
15.
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
Haematologica
; 104(2): 380-391, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262560
16.
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 24(1): 50-54, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958896
17.
Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.
Biol Blood Marrow Transplant
; 24(2): 308-313, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032276
18.
Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma.
Biol Blood Marrow Transplant
; 24(11): 2211-2215, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30454872
19.
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.
Blood
; 127(11): 1502-8, 2016 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26764356
20.
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Haematologica
; 108(1): 273-277, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134457